Molecular mechanisms of glucocorticoid action in mast cells

Molecular and Cellular Endocrinology

Volumn 380, Issue 1-2, 2013, Pages 119-126

  Oppong, Emmanuel ^a   Flink, Nesrin ^a   Cato, Andrew C B ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Allergy; Mast cells; Protein tyrosine phosphatases

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 10; DUAL SPECIFICITY PHOSPHATASE 14; DUAL SPECIFICITY PHOSPHATASE 16; DUAL SPECIFICITY PHOSPHATASE 18; DUAL SPECIFICITY PHOSPHATASE 19; DUAL SPECIFICITY PHOSPHATASE 2; DUAL SPECIFICITY PHOSPHATASE 22; DUAL SPECIFICITY PHOSPHATASE 23; DUAL SPECIFICITY PHOSPHATASE 3; DUAL SPECIFICITY PHOSPHATASE 4; DUAL SPECIFICITY PHOSPHATASE 5; DUAL SPECIFICITY PHOSPHATASE 6; DUAL SPECIFICITY PHOSPHATASE 7; DUAL SPECIFICITY PHOSPHATASE 8; DUAL SPECIFICITY PHOSPHATASE 9; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE A; PROTEIN TYROSINE PHOSPHATASE B; PROTEIN TYROSINE PHOSPHATASE C; STEM CELL FACTOR; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CELL ACTIVITY; DRUG MECHANISM; DUSP1 GENE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE; HUMAN; MAST CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ALLERGY; ANTIGEN PRESENTING CELL; APC; BMMC; BONE MARROW DERIVED MAST CELLS; C-JUN N-TERMINAL KINASES; DOK 1; DOKING PROTEIN 1; DUAL SPECIFICITY PHOSPHATASE; DUSP; ERK; EXTRACELLULAR REGULATED KINASES; FITC; FLUORESCEIN ISOTHIOCYANATE; GAB2; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RESPONSE ELEMENTS; GR; GRB2-ASSOCIATED BINDER 2; GRE; IGE; IL; IMMUNOGLOBULIN E; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIFS; INOSITOL 1,4,5-TRISPHOSPHATE; INTERLEUKIN; IP3; ITAM; JNK; LAT; LINKER OF ACTIVATION OF T-CELLS; MAPK; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE; NON-T-CELL ACTIVATION LINKER; NTAL; PEP; PHOSPHATIDYLINOSITOL (3,4,5)-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE C; PI3K; PIP2; PIP3; PLC; PROLINE-, GLUTAMIC ACID-, SERINE- AND THREONINE-RICH (PEST)-DOMAIN ENRICHED TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASES; PTP; SH2 DOMAIN CONTAINING LEUKOCYTE PROTEIN OF 76KDA; SH2 DOMAIN CONTAINING POLYINOSITOL-5PHOSPHATASE 1; SHIP1; SLAP; SLP-76; SPLEEN TYROSINE KINASE; SRC-LIKE ADAPTOR PROTEIN; SYK; TNFΑ; TUMOUR NECROSIS FACTOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MAST CELLS; SIGNAL TRANSDUCTION;

EID: 84884530551     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.05.014     Document Type: Article

References (106)

1. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., Clark A.R. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 2006, 203:1883-1889.
2. Abramson J., Rozenblum G., Pecht I. Dok protein family members are involved in signaling mediated by the type 1 Fc epsilon receptor. Eur. J. Immunol. 2003, 33:85-91.
3. Alonso A., Saxena M., Williams S., Mustelin T. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J. Biol. Chem. 2001, 276:4766-4771.
4. Alonso A., Merlo J.J., Na S., Kholod N., Jaroszewski L., Kharitonenkov A., Williams S., Godzik A., Posada J.D., Mustelin T. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J. Biol. Chem. 2002, 277:5524-5528.
5. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 2004, 117:699-711.
6. Alvarez-Errico D., Lessmann E., Rivera J. Adapters in the organization of mast cell signaling. Immunol. Rev. 2009, 232:195-217.
7. Andrade M.V., Hiragun T., Beaven M.A. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J. Immunol. 2004, 172:7254-7262.
8. Aoyama K., Nagata M., Oshima K., Matsuda T., Aoki N. Molecular cloning and characterization of a novel dual specificity phosphatase, LMW-DSP2, that lacks the cdc25 homology domain. J. Biol. Chem. 2001, 276:27575-27583.
9. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (London) 1998, 94:557-572.
10. Bayόn, Y., Alonso, A., 2010. Atypical DUSPs: 19 phosphatases in search of a role. In: Pedro, A.L. (Ed.), Emerging Signalling Pathways in, Tumour Biology, pp. 185-208.
11. Benhamou M., Ninio E., Salem P., Hieblot C., Bessou G., Pitton C., Liu F.T., Mencia-Huerta J.M. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone. J. Immunol. 1986, 136:1385-1392.
12. Biddie S.C., John S., Sabo P.J., Thurman R.E., Johnson T.A., Schiltz R.L., Miranda T.B., Sung M.H., Trump S., Lightman S.L., Vinson C., Stamatoyannopoulos J.A., Hager G.L. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 2011, 43:145-155.
13. Cato, A.C., Nestl, A., Mink, S., 2002. Rapid actions of steroid receptors in cellular signaling pathways, Sci STKE. 2002, re9.
14. Caunt C.J., Rivers C.A., Conway-Campbell B.L., Norman M.R., McArdle C.A. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases. J. Biol. Chem. 2008, 283:6241-6252.
15. Chen A.J., Zhou G., Juan T., Colicos S.M., Cannon J.P., Cabriera-Hansen M., Meyer C.F., Jurecic R., Copeland N.G., Gilbert D.J., Jenkins N.A., Fletcher F., Tan T.H., Belmont J.W. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway. J. Biol. Chem. 2002, 277:36592-36601.
16. Chinenov Y., Gupte R., Dobrovolna J., Flammer J.R., Liu B., Michelassi F.E., Rogatsky I. Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. Proc. Natl. Acad. Sci. USA 2012, 109:11776-11781.
17. Chu Y., Solski P.A., Khosravi-Far R., Der C.J., Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 1996, 271:6497-6501.
18. Cissel D.S., Beaven M.A. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 2000, 275:7066-7070.
19. Cloutier J.F., Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 1999, 189:111-121.
20. Cohen S., Dadi H., Shaoul E., Sharfe N., Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999, 93:2013-2024.
21. Croxtall J.D., Choudhury Q., Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br. J. Pharmacol. 2000, 130:289-298.
22. Da Silva C., Reber L., Frossard N. Stem cell factor expression, mast cells and inflammation in asthma. Fund. Clin. Pharmacol. 2006, 20:21-39.
23. Dickinson R.J., Delavaine L., Cejudo-Marin R., Stewart G., Staples C.J., Didmon M.P., Trinidad A.G., Alonso A., Pulido R., Keyse S.M. Phosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways. J. Biol. Chem. 2011, 286:38018-38026.
24. Dimov V.V., Casale T.B. Immunomodulators for asthma. Allergy Asthma Immunol. Res. 2010, 2:228-234.
25. Eiseman E., Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992, 355:78-80.
26. Farooq A., Zhou M.M. Structure and regulation of MAPK phosphatases. Cell Signal. 2004, 16:769-779.
27. Fauman E.B., Saper M.A. Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 1996, 21:413-417.
28. Finotto S., Mekori Y.A., Metcalfe D.D. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 1997, 99:1721-1728.
29. Franklin C.C., Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 1997, 272:16917-16923.
30. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
31. Gilfillan A.M., Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 2009, 228:149-169.
32. Goldsmith P., McGarity B., Walls A.F., Church M.K., Millward-Sadler G.H., Robertson D.A. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig. Dis. Sci. 1990, 35:1409-1413.
33. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell Endocrinol. 2007, 275:2-12.
34. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 1996, 15:3621-3632.
35. Haller J., Mikics E., Makara G.B. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front. Neuroendocrinol. 2008, 29:273-291.
36. Hammer M., Mages J., Dietrich H., Servatius A., Howells N., Cato A.C., Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 2006, 203:15-20.
37. Hasegawa K., Martin F., Huang G., Tumas D., Diehl L., Chan A.C. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004, 303:685-689.
38. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H.J., Herrlich P., Cato A.C. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 1994, 13:4087-4095.
39. Hench P.S., Kendall E.C., Slocumb C.H., Polley H.F. Cortisone, its effects on rheumatoid arthritis, rheumatic fever, and certain other conditions. Merck Rep. 1950, 59:9-14.
40. Hench P.S., Slocumb C.H., Polley H.F., Kendal E.C. Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases. J. Am. Med. Assoc. 1950, 144:1327-1335.
41. Hiragun T., Peng Z., Beaven M.A. Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells. Mol. Pharmacol. 2005, 67:598-603.
42. Hiragun T., Peng Z., Beaven M.A. Cutting edge: dexamethasone negatively regulates Syk in mast cells by up-regulating SRC-like adaptor protein. J. Immunol. 2006, 177:2047-2050.
43. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 1998, 95:11330-11335.
44. Hudson W.H., Youn C., Ortlund E.A. The structural basis of direct glucocorticoid-mediated transrepression. Nat. Struct. Mol. Biol. 2013, 20:53-58.
45. Jeffrey K.L., Brummer T., Rolph M.S., Liu S.M., Callejas N.A., Grumont R.J., Gillieron C., Mackay F., Grey S., Camps M., Rommel C., Gerondakis S.D., Mackay C.R. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nat. Immunol. 2006, 7:274-283.
46. Jeong H.J., Na H.J., Hong S.H., Kim H.M. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 2003, 144:4080-4086.
47. Johansson-Haque K., Palanichamy E., Okret S. Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J. Mol. Endocrinol. 2008, 41:239-249.
48. Kassel O., Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol. Cell. Endocrinol. 2007, 275:13-29.
49. Kassel O., Schmidlin F., Duvernelle C., de Blay F., Frossard N. Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol. Pharmacol. 1998, 54:1073-1079.
50. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001, 20:7108-7116.
51. Kassel O., Schneider S., Heilbock C., Litfin M., Gottlicher M., Herrlich P. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kB-regulated promoters. Genes Dev. 2004, 18:2518-2528.
52. Keyse S.M. Protein phosphatases and the regulation of MAP kinase activity. Semin. Cell Dev. Biol. 1998, 9:143-152.
53. Keyse S.M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008, 27:253-261.
54. Kitamura Y., Go S., Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978, 52:447-452.
55. Kraft S., Kinet J.P. New developments in Fc epsilonRI regulation, function and inhibition. Nat. Rev. Immunol. 2007, 7:365-378.
56. Lang R., Hammer M., Mages J. DUSP meet Immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 2006, 177:7497-7504.
57. Lavker R.M., Schechter N.M. Cutaneous mast cell depletion results from topical corticosteroid usage. J. Immunol. 1985, 135:2368-2373.
58. Liu C., Zhou J., Zhang L.D., Wang Y.X., Kang Z.M., Chen Y.Z., Jiang C.L. Rapid inhibitory effect of corticosterone on histamine release from rat peritoneal mast cells. Horm. Metab. Res. 2007, 39:273-277.
59. Lowenberg M., Verhaar A.P., Bilderbeek J., Marle J., Buttgereit F., Peppelenbosch M.P., van Deventer S.J., Hommes D.W. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 2006, 7:1023-1029.
60. Luecke H.F., Yamamoto K.R. The glucocorticoid receptor blocks P-TEFb recruitment by NF-kB to effect promoter-specific transcriptional repression. Genes Dev. 2005, 19:1116-1127.
61. Maier J.V., Brema S., Tuckermann J., Herzer U., Klein M., Stassen M., Moorthy A., Cato A.C. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol. Endocrinol. 2007, 21:2663-2671.
62. Mandl M., Slack D.N., Keyse S.M. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5. Mol. Cell Biol. 2005, 25:1830-1845.
63. Marti F., Krause A., Post N.H., Lyddane C., Dupont B., Sadelain M., King P.D. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J. Immunol. 2001, 166:197-206.
64. Matthews L., Berry A., Ohanian V., Ohanian J., Garside H., Ray D. Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol. Endocrinol. 2008, 22:1320-1330.
65. Meininger C.J., Yano H., Rottapel R., Bernstein A., Zsebo K.M., Zetter B.R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992, 79:958-963.
66. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 1997, 77:1033-1079.
67. Metcalfe D.D., Peavy R.D., Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. J. Allergy Clin. Immunol. 2009, 124:639-646. quiz 647-8.
68. Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C., Davies K., Ashworth A., Arkinstall S. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 1996, 271:27205-27208.
69. Nakamura K., Tanoue K., Satoh T., Takekawa M., Watanabe M., Shima H., Kikuchi K. A novel low-molecular-mass dual-specificity phosphatase, LDP-2, with a naturally occurring substitution that affects substrate specificity. J. Biochem. 2002, 132:463-470.
70. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., Asai H., Yonezawa T., Kitamura Y., Galli S.J. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 1985, 162:1025-1043.
71. Nilsson G., Butterfield J.H., Nilsson K., Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 1994, 153:3717-3723.
72. Obiri D.D., Flink N., Maier J.V., Neeb A., Maddalo D., Thiele W., Menon A., Stassen M., Kulkarni R.A., Garabedian M.J., Barrios A.M., Cato A.C. PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice. Allergy 2012, 67:175-182.
73. Olefsky J.M. Nuclear receptor minireview series. J. Biol. Chem. 2001, 276:36863-36864.
74. On M., Billingsley J.M., Jouvin M.H., Kinet J.P. Molecular dissection of the FcRbeta signaling amplifier. J. Biol. Chem. 2004, 279:45782-45790.
75. Ott V.L., Tamir I., Niki M., Pandolfi P.P., Cambier J.C. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling. J. Immunol. 2002, 168:4430-4439.
76. Raugei G., Ramponi G., Chiarugi P. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol. Life Sci. 2002, 59:941-949.
77. Rider L.G., Hirasawa N., Santini F., Beaven M.A. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J. Immunol. 1996, 157:2374-2380.
78. Rivera J. Molecular adapters in Fc(epsilon)RI signaling and the allergic response. Curr. Opin. Immunol. 2002, 14:688-693.
79. Rivera J., Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 2006, 117:1214-1225. quiz 1226.
80. Robin J.L., Seldin D.C., Austen K.F., Lewis R.A. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol. 1985, 135:2719-2726.
81. Sanderson M.P., Wex E., Kono T., Uto K., Schnapp A. Syk and Lyn mediate distinct Syk phosphorylation events in FcvarepsilonRI-signal transduction: implications for regulation of IgE-mediated degranulation. Mol. Immunol. 2010, 48:171-178.
82. Saxena M., Mustelin T. Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin. Immunol. 2000, 12:387-396.
83. Scharenberg A.M., Lin S., Cuenod B., Yamamura H., Kinet J.P. Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. EMBO J. 1995, 14:3385-3394.
84. Schwartz L.B. Mast cells: function and contents. Curr. Opin. Immunol. 1994, 6:91-97.
85. Shipp L.E., Lee J.V., Yu C.Y., Pufall M., Zhang P., Scott D.K., Wang J.C. Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PLoS One 2010, 5:e13754.
86. Stahn C., Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 2008, 4:525-533.
87. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., Li M., Chambon P. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
88. Takagaki K., Satoh T., Tanuma N., Masuda K., Takekawa M., Shima H., Kikuchi K. Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38. Biochem. J. 2004, 383:447-455.
89. Tanoue T., Moriguchi T., Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 1999, 274:19949-19956.
90. Tanoue T., Yamamoto T., Maeda R., Nishida E. A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J. Biol. Chem. 2001, 276:26629-26639.
91. Tchen C.R., Martins J.R., Paktiawal N., Perelli R., Saklatvala J., Clark A.R. Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J. Biol. Chem. 2010, 285:2642-2652.
92. Tkaczyk C., Horejsi V., Iwaki S., Draber P., Samelson L.E., Satterthwaite A.B., Nahm D.H., Metcalfe D.D., Gilfillan A.M. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation. Blood 2004, 104:207-214.
93. Todd J.L., Rigas J.D., Rafty L.A., Denu J.M. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK). Oncogene 2002, 21:2573-2583.
94. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
95. Tshori S., Nechushtan H. Mast cell transcription factors-regulators of cell fate and phenotype. Biochim. Biophys. Acta. 2012, 1822:42-48.
96. Turner H., Kinet J.P. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999, 402:B24-B30.
97. Vonakis B.M., Chen H., Haleem-Smith H., Metzger H. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J. Biol. Chem. 1997, 272:24072-24080.
98. Wilson B.S., Pfeiffer J.R., Oliver J.M. Observing Fc epsilonRI signaling from the inside of the mast cell membrane. J. Cell Biol. 2000, 149:1131-1142.
99. Wu J.J., Bennett A.M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J. Biol. Chem. 2005, 280:16461-16466.
100. Wu Q., Li Y., Gu S., Li N., Zheng D., Li D., Zheng Z., Ji C., Xie Y., Mao Y. Molecular cloning and characterization of a novel dual-specificity phosphatase 23 gene from human fetal brain. Int. J. Biochem. Cell Biol. 2004, 36:1542-1553.
101. Wu Q., Huang S., Sun Y., Gu S., Lu F., Dai J., Yin G., Sun L., Zheng D., Dou C., Feng C., Ji C., Xie Y., Mao Y. Dual specificity phosphotase 18, interacting with SAPK, dephosphorylates SAPK and inhibits SAPK/JNK signal pathway in vivo. Front. Biosci. 2006, 11:2714-2724.
102. Yamaguchi M., Hirai K., Komiya A., Miyamasu M., Furumoto Y., Teshima R., Ohta K., Morita Y., Galli S.J., Ra C., Yamamoto K. Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int. Immunol. 2001, 13:843-851.
103. Yamashita T., Mao S.Y., Metzger H. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 1994, 91:11251-11255.
104. Zama T., Aoki R., Kamimoto T., Inoue K., Ikeda Y., Hagiwara M. A novel dual specificity phosphatase SKRP1 interacts with the MAPK kinase MKK7 and inactivates the JNK MAPK pathway. Implication for the precise regulation of the particular MAPK pathway. J. Biol. Chem. 2002, 277:23909-23918.
105. Zhou J., Liu D.F., Liu C., Kang Z.M., Shen X.H., Chen Y.Z., Xu T., Jiang C.L. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy 2008, 63:1177-1185.
106. Zhu Q.Y., Liu Q., Chen J.X., Lan K., Ge B.X. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J. Immunol. 2010, 185:7435-7442.